Gene therapy trial for chronic hepatitis B
Part of Digestive system, Infections clinical trials.
This trial tests a gene therapy called PBGENE-HBV for people with chronic hepatitis B who are already on antiviral treatment. The goal is to see if it is safe and can help control the virus.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are male or a woman who cannot become pregnant
- Your body mass index (BMI) is between 18 and 35
- You have had chronic hepatitis B for at least 12 months
- You are hepatitis B e-antigen negative
- Your hepatitis B virus is well-controlled by current antiviral medication
- You do not have cirrhosis or liver cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, AHB-137, in people with chronic hepatitis B who are already on a stable antiviral treatment. It aims to see if AHB-137 can help lower the virus further or improve outcomes.
This study tests a new medicine called AHB-137 for people with chronic hepatitis B who are HBeAg negative and currently on antiviral therapy. The goal is to see if it can help control the virus better or allow you to stop your current medication safely.
This trial tests a drug called Bepirovirsen for people with chronic hepatitis B who have low levels of the virus marker (HBsAg). It aims to see if the drug can help control the infection, and involves a liver biopsy to check the liver.
This study tests a new antibody treatment (VIR-3434) for chronic hepatitis B. It aims to see if the antibody can help your immune system control the virus, potentially allowing you to stop your current antiviral medication later.
This trial tests a sequence of pegylated interferon (PEG-IFN) shots for people with chronic hepatitis B who have already had a significant drop in their virus levels after taking a newer type of RNA-targeting medicine. The goal is to see if this approach can help clear the virus even further.
This trial studies whether pegylated interferon can help people with inactive chronic hepatitis B stay stable or improve outcomes. You may qualify if your virus levels and liver blood tests are currently low and you’ve never used antiviral treatments.
Hear when a new HEPATITIS B CHRONIC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.